Real-time visibility technology provider Tive announced on Thursday that it has developed a new collection of trackers designed to support the pharmaceutical industry’s deliveries of biologics and cell gene therapies.
“There have been tremendous developments in biologic medicines over the past 10 to 15 years, which means the drug base is alive, including vaccines, insulin and oncology products,” said Alex Guillen, sales manager for life sciences and pharmaceuticals for Tive. “These products have to be stored at extremely low temperatures, which makes it difficult to transport them around the world.”
In an interview with FreightWaves, Guillen described ultra-low temperature pharmaceutical therapies, including cell and gene therapies, used in regenerative medicine and supported by cryogenic temperature-controlled shipments.
To support these unique shipments, Tive has developed four products that can keep medications in a wide range of temperatures during transit – the Solo 5g Pharma Tracker (-30°C to 60°C), the Solo 5g Pharma Non-Lithium Tracker ( minus 30 °C to 60 °C), the GxP-compliant probes for dry ice (minus 100 °C to 50 °C) and for cryogenic shipments (minus 200 °C to minus 50 °C).
“A lot of innovation comes from these new therapies, and our customers were afraid that they had developed the best drug in the world but couldn’t deliver it,” said Guillen.
One of Tive’s customers, Biocair, a global life sciences logistics specialist, uses Tive’s products to offer this niche of customers a proactive approach to solving supply chain problems.
“Biocair wants the best of the best, and that’s why we use Tive: they offer a complete cold chain solution that allows us to be proactive rather than reactive – at every point in the supply chain,” says Robert Pagan, Packaging Solutions Engineer at Biocair. “We are an extremely customer-centric company, and by using Tive we show our customers that we are at the cutting edge of technology and medicine – to serve them better and differentiate ourselves from the competition.”
Guillen said he takes pride in transporting products that save lives.
“In clinical trials of new drugs, you look for side effects. In phase two you are looking for an efficient product. In phase three, you’re already working with patients, many with rare diseases with no cure, and they’re waiting for this miracle drug to be bottled,” Guillen said. “If this drug doesn’t arrive or arrive and it’s not intact, someone could die. … These new ones [Tive] Products have a purpose.”
All four new products are available for customers to order now and will be available for bulk commercial orders in the coming weeks.
Watch now: Tive’s new temperature logging label
Tive raises $54 million to expand shipment tracking system sales worldwide
Tive introduces temperature record label
FourKites, Tive partner for mutual customers